The wearable cardioverter-defibrillator: Current technology and evolving indications

Sven Reek*, Haran Burri, Paul R. Roberts, Christian Perings, Andrew E. Epstein, Helmut U. Klein, Gregory Y H Lip, Bulent Gorenek, Christian Sticherling, Laurent Fauchier, Andreas Goette, Werner Jung, Marc A. Vos, Michele Brignole, Christian Elsner, Gheorghe Andrei Dan, Francisco Marin, Giuseppe Boriani, Deirdre Lane, Carina Blomstrom LundqvistIrina Savelieva,

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

The wearable cardioverter-defibrillator has been available for over a decade and now is frequently prescribed for patients deemed at high arrhythmic risk in whom the underlying pathology is potentially reversible or who are awaiting an implantable cardioverter-defibrillator. The use of the wearable cardioverter-defibrillator is included in the new 2015 ESC guidelines for the management of ventricular arrhythmias and prevention of sudden cardiac death. The present review provides insight into the current technology and an overview of this approach.

Original languageEnglish
Pages (from-to)335-345
Number of pages11
JournalEuropace
Volume19
Issue number3
DOIs
Publication statusPublished - 2017

Keywords

  • External defibrillation
  • Life vest
  • Sudden cardiac death
  • Ventricular arrhythmias
  • Wearable cardioverter-defibrillator

Fingerprint

Dive into the research topics of 'The wearable cardioverter-defibrillator: Current technology and evolving indications'. Together they form a unique fingerprint.

Cite this